The Journal of allergy and clinical immunology
-
J. Allergy Clin. Immunol. · Jun 1999
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialComparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Salmeterol, a long-acting beta2 -agonist, and zafirlukast, a leukotriene receptor antagonist, are both indicated for the treatment of asthma in adolescent and adult patients. ⋯ In patients with persistent asthma, most of whom were concurrently using inhaled corticosteroids, treatment with inhaled salmeterol provided significantly greater improvement than oral zafirlukast in overall asthma control over the 4-week treatment period.